Table 2.
Meta-analyses of anesthetic technique and breast cancer recurrence.
| Ref. (year) | Cancer type (patient n) | Surgery type | Anesthetic technique | Outcomes | Benefit/remarks |
|---|---|---|---|---|---|
| 111 (2017) | Gastrointestinal, breast, prostate, ovarian (n = 67,577) | Cancer surgery | RA/inhalation anesthesia vs. inhalation anesthesia | No difference in OS, RFS, or BRFS Some benefit of OS in RCT on colorectal cancer |
Negative |
| 112 (2019) | Breast, esophageal, NSLC (n = 7866) Breast, colorectal, gastric, esophageal, NSLC, mixed (n = 18,778) |
Radical cancer surgery | Propofol TIVA vs. inhalation anesthesia | Improved RFS with TIVA Improved OS with TIVA |
Positive |
RCT, randomized controlled trial; NSLC, non-small cell lung cancer; BRFS, biochemical recurrence-free survival.